Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]
Presentation on GIST Treatment after "Standard" Therapy by Dr. Jonathan Trent, Professor of Medicine, Co-Director Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center. Over 80 GISTers and their loved ones gathered [...]
Mo Collins Are you interested in learning about how others live with GIST? Do you have questions about patient assistance programs, treatment options and the nutritional and emotional aspects of GIST? Join us [...]
Increased tearing, or epiphoria, can be a side effect of your GIST treatment. There are a number of strategies to cope with increased tearing. Keep reading for more information.Here are a few strategies to try [...]
ASCO features many updates on GIST trials. Promising results for the immunotherapy approach to treating cancer dominated the annual conference of the ASCO and represent one of the biggest developments in cancer research since the advent [...]
A new blood test technology may lead to major changes in treatment of Gastrointestinal Stromal Tumors. Keep reading for more information.
Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.
Renee Simmons of Patient Services, Inc presents this webcast titled "PSI: Your Financial Safety Net in Times of Need."